ECOG 1505 Study: No Benefit of Post-Operative Avastin in Early Stage Lung Cancer Patients

ECOG 1505 Study: No Benefit of Post-Operative Avastin in Early Stage Lung Cancer Patients

From: GRACEcast
0 0 5 years ago
Drs. Ben Solomon, Leora Horn, & Jack West review trial result and implications of ECOG 1505 trial that showed no benefit to addition of Avastin (bevacizumab) to adjuvant chemotherapy for early stage NSCLC.

Find us on Facebook